Drugs / ABP-700
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02800590 | May 2016 → Jun 2017 | — | The Medicines Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABP-700 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02800590 ↗ |
| Modality | Small molecule | — CHEMBL4297255 ↗ |
| Route | Intravenous | “intravenous (IV) infusion” NCT02800590 ↗ |